[关键词]
[摘要]
基于以往涉及冠状病毒疫苗的相关专利信息,对其现状和发展趋势进行分析。自从2002年严重急性呼吸道系统综合征(SARS)暴发以来,冠状病毒疫苗专利申请量在2003年达到高峰;自从2012年中东呼吸综合征暴发以来,冠状病毒疫苗专利申请量在2012~2015年有小幅增长。从重点申请人和疫苗类型的分析得出,目前针对冠状病毒以核酸疫苗、灭活疫苗和病毒载体疫苗为主,这也与我国和美国已经进入临床试验的新型冠状病毒(SARS-CoV-2)3类疫苗类型相吻合。
[Key word]
[Abstract]
Based on the patent information related to coronavirus vaccine, the present situation and development trend of coronavirus vaccine have been analyzed. Since the outbreak of SARS in 2002, the amount of patent applications of coronavirus vaccine reached the peak in 2003. Since the outbreak of Middle East respiratory syndrome in 2012, there was a small increase on the amount of patent applications of coronavirus vaccine from 2012 to 2015. In view of the analyses of the key applicants and vaccine types, it is concluded that nucleic acid vaccine, inactivated vaccine and viral vector vaccine are the main vaccine types against coronavirus, which is consistent with the three types of vaccines that have entered clinical trials in China and the United States.
[中图分类号]
[基金项目]